Sign Up Today and Learn More About Mindstrong Stock
Invest in or calculate the value of your shares in Mindstrong or other pre-IPO companies through EquityZen's platform.
About Mindstrong Stock
Founded
2014
Headquarters
Mountain View, CA, US
Total Funding
14.0M
Industries
Health Care, Mobile
Mindstrong's patented science and technology was developed by Dr. Dagum, and is based on four years of extensive clinical studies applying machine intelligence to human-computer interactions patterns. Dr. Dagum's work creates, for the first time, a way to objectively and continuously measure brain function day-to-day providing new insight not previously possible with traditional neuropsychological and imaging techniques. Mindstrong products are in clinical trials in numerous partnership projects with payers, providers, academics and the pharmaceutical industry to bring these new tools to bear on answering the most fundamental questions in behavioral health.
Mindstrong Press Mentions
Stay in the know about the latest news on Mindstrong
How Family Offices Can Join The Health Tech Revolution
wealthbriefing • Jun 08, 2021
Livongo's lead investor on what the next model of care could look like
mobihealthnews • Oct 09, 2020
COVID-19 accelerates healthtech adoption
healthtechpulse • Jun 09, 2020
Mindstrong Bag $100m Investment, Plans to Scale Its Offering
venture-med • Jun 02, 2020
Mindstrong scores $100M to monitor wellness via smartphone behaviors
bit • May 23, 2020
Investors in Mindstrong
Discover investors in Mindstrong stock and explore their portfolio companies
Mindstrong Management
Leadership team at Mindstrong
Chief Executive Officer
Michelle Wagner
Chief Technology Officer
Miguel Alvarado
Join now and verify your accreditation status to gain access to:
- Mindstrong current valuation
- Mindstrong stock price
- Available deals in Mindstrong and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Mindstrong stock?
Accredited investors can buy pre-IPO stock in companies like Mindstrong through EquityZen funds. These investments are made available by existing Mindstrong shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Mindstrong stock?
Shareholders can sell their Mindstrong stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
